The global biochips market size reached US$ 14.6 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 35.4 Billion by 2027, exhibiting a growth rate (CAGR) of 15.94% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor. Biochips refer to a miniaturized medical device that includes a wide collection of microarrays for performing multiple biochemical reactions simultaneously. They contain numerous biosensors that enable the screening of several biological analytes such as enzymes, proteins, DNA, biological molecules, antibodies, etc. Biochips are primarily used in drug discovery, in-vitro diagnostics, gene expression profiling, single nucleotide polymorphism genotyping, agricultural biotechnology, etc. As a result, they are widely adopted across various pharmaceutical and biotechnology companies, research and academic laboratories, and healthcare facilities. The increasing prevalence of chronic disorders along with the rising geriatric population is currently driving the demand for biochips in the medical sector. In recent times, the growing incidences of cancer have also augmented the use of biochips for the early detection of cancerous cells in the body. In line with this, biochips are increasingly being adopted for developing targeted and personalized medicines for cancer treatment. Additionally, the growing consumer health concerns towards several viral infections and immunological disorders are also propelling the demand for biochips in new drug discovery and development activities. For instance, with the outbreak of the COVID-19 pandemic, several biotechnology and pharma companies are focusing on developing novel biochips for detecting the infection in the body. Moreover, rising advancements in microfluid technology have led to the introduction of specifically engineered biochips for various laboratory procedures. Furthermore, numerous R&D activities in the biotechnology sector have also led to the emergence of digital microfluidic biochips. The changing consumer inclination towards minimally invasive surgeries coupled with rising upgradations in nanotechnology are further driving the demand for biochips. Apart from this, the growing investments in the healthcare sector pertaining to cancer genomics, human proteome, and DNA-analysis are further anticipated to catalyze the global biochips market. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global biochips market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, fabrication technique, analysis method, application and end user. Breakup by Product Type: DNA Chip Protein Chip Lab-On-a-Chip Enzyme Chip Breakup by Fabrication Technique: Microarray Microfluidic Breakup by Analysis Method: Electrophoresis Luminescence Mass Spectrometry Electrical Signals Magnetism Breakup by Application: Molecular Analysis Hybridization Protein Immunological Biomolecules Biomarker Others Diagnosis Gene Diagnosis Oncology Inflammatory Others Non-Biological Usage Breakup by End User: Pharmaceutical and Biotechnology Companies Hospitals and Diagnostics Centers Academic & Research Institutes Others Breakup by Region: North America United States Canada Europe Germany France United Kingdom Spain Russia Italy Others Asia Pacific China Japan India South Korea Australia Others Latin America Mexico Brazil Argentina Others Middle East and Africa Turkey Saudi Arabia United Arab Emirates Others Competitive Landscape: The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies, Inc., bioMérieux SA, Bio-RAD Laboratories, Inc., CapitalBio Corporation, Dynamic Biosensors GmbH, EMD Millipore Corporation, Fluidigm Corporation, Illumina, Inc., Perkinelmer, Inc., and Thermo Fisher Scientific Inc. Key Questions Answered in This Report: How has the global biochips market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global biochips market? What are the key regional markets? What is the breakup of the market based on the product type? What is the breakup of the market based on the fabrication technique? What is the breakup of the market based on the analysis method? What is the breakup of the market based on the application? What is the breakup of the market based on the end user? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the market? What is the structure of the global biochips market and who are the key players? What is the degree of competition in the market?

1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Biochips Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Product Type 6.1 DNA Chip 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Protein Chip 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Lab-On-a-Chip 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Enzyme Chip 6.4.1 Market Trends 6.4.2 Market Forecast 7 Market Breakup by Fabrication Technique 7.1 Microarray 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Microfluidic 7.2.1 Market Trends 7.2.2 Market Forecast 8 Market Breakup by Analysis Method 8.1 Electrophoresis 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Luminescence 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Mass Spectrometry 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Electrical Signals 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 Magnetism 8.5.1 Market Trends 8.5.2 Market Forecast 9 Market Breakup by Application 9.1 Molecular Analysis 9.1.1 Hybridization 9.1.1.1 Market Trends 9.1.1.2 Market Forecast 9.1.2 Protein 9.1.2.1 Market Trends 9.1.2.2 Market Forecast 9.1.3 Immunological 9.1.3.1 Market Trends 9.1.3.2 Market Forecast 9.1.4 Biomolecules 9.1.4.1 Market Trends 9.1.4.2 Market Forecast 9.1.5 Biomarker 9.1.5.1 Market Trends 9.1.5.2 Market Forecast 9.1.6 Others 9.1.6.1 Market Trends 9.1.6.2 Market Forecast 9.2 Diagnosis 9.2.1 Gene Diagnosis 9.2.1.1 Market Trends 9.2.1.2 Market Forecast 9.2.2 Oncology 9.2.2.1 Market Trends 9.2.2.2 Market Forecast 9.2.3 Inflammatory 9.2.3.1 Market Trends 9.2.3.2 Market Forecast 9.2.4 Others 9.2.4.1 Market Trends 9.2.4.2 Market Forecast 9.3 Non-Biological Usage 9.3.1 Market Trends 9.3.2 Market Forecast 10 Market Breakup by End User 10.1 Pharmaceutical and Biotechnology Companies 10.1.1 Market Trends 10.1.2 Market Forecast 10.2 Hospitals and Diagnostics Centers 10.2.1 Market Trends 10.2.2 Market Forecast 10.3 Academic & Research Institutes 10.3.1 Market Trends 10.3.2 Market Forecast 10.4 Others 10.4.1 Market Trends 10.4.2 Market Forecast 11 Market Breakup by Region 11.1 North America 11.1.1 United States 11.1.1.1 Market Trends 11.1.1.2 Market Forecast 11.1.2 Canada 11.1.2.1 Market Trends 11.1.2.2 Market Forecast 11.2 Europe 11.2.1 Germany 11.2.1.1 Market Trends 11.2.1.2 Market Forecast 11.2.2 France 11.2.2.1 Market Trends 11.2.2.2 Market Forecast 11.2.3 United Kingdom 11.2.3.1 Market Trends 11.2.3.2 Market Forecast 11.2.4 Spain 11.2.4.1 Market Trends 11.2.4.2 Market Forecast 11.2.5 Russia 11.2.5.1 Market Trends 11.2.5.2 Market Forecast 11.2.6 Italy 11.2.6.1 Market Trends 11.2.6.2 Market Forecast 11.2.7 Others 11.2.7.1 Market Trends 11.2.7.2 Market Forecast 11.3 Asia Pacific 11.3.1 China 11.3.1.1 Market Trends 11.3.1.2 Market Forecast 11.3.2 India 11.3.2.1 Market Trends 11.3.2.2 Market Forecast 11.3.3 Japan 11.3.3.1 Market Trends 11.3.3.2 Market Forecast 11.3.4 South Korea 11.3.4.1 Market Trends 11.3.4.2 Market Forecast 11.3.5 Australia 11.3.5.1 Market Trends 11.3.5.2 Market Forecast 11.3.6 Others 11.3.6.1 Market Trends 11.3.6.2 Market Forecast 11.4 Latin America 11.4.1 Mexico 11.4.1.1 Market Trends 11.4.1.2 Market Forecast 11.4.2 Brazil 11.4.2.1 Market Trends 11.4.2.2 Market Forecast 11.4.3 Argentina 11.4.3.1 Market Trends 11.4.3.2 Market Forecast 11.4.4 Others 11.4.4.1 Market Trends 11.4.4.2 Market Forecast 11.5 Middle East and Africa 11.5.1 Turkey 11.5.1.1 Market Trends 11.5.1.2 Market Forecast 11.5.2 Saudi Arabia 11.5.2.1 Market Trends 11.5.2.2 Market Forecast 11.5.3 United Arab Emirates 11.5.3.1 Market Trends 11.5.3.2 Market Forecast 11.5.4 Others 11.5.4.1 Market Trends 11.5.4.2 Market Forecast 12 SWOT Analysis 12.1 Overview 12.2 Strengths 12.3 Weaknesses 12.4 Opportunities 12.5 Threats 13 Value Chain Analysis 14 Porters Five Forces Analysis 14.1 Overview 14.2 Bargaining Power of Buyers 14.3 Bargaining Power of Suppliers 14.4 Degree of Competition 14.5 Threat of New Entrants 14.6 Threat of Substitutes 15 Competitive Landscape 15.1 Market Structure 15.2 Key Players 15.3 Profiles of Key Players 15.3.1 Agilent Technologies, Inc 15.3.1.1 Company Overview 15.3.1.2 Product Portfolio 15.3.1.3 Financials 15.3.1.4 SWOT Analysis 15.3.2 bioMérieux SA 15.3.2.1 Company Overview 15.3.2.2 Product Portfolio 15.3.2.3 Financials 15.3.2.4 SWOT Analysis 15.3.3 Bio-RAD Laboratories, Inc 15.3.3.1 Company Overview 15.3.3.2 Product Portfolio 15.3.3.3 Financials 15.3.3.4 SWOT Analysis 15.3.4 CapitalBio Corporation 15.3.4.1 Company Overview 15.3.4.2 Product Portfolio 15.3.5 Dynamic Biosensors GmbH 15.3.5.1 Company Overview 15.3.5.2 Product Portfolio 15.3.6 EMD Millipore Corporation 15.3.6.1 Company Overview 15.3.6.2 Product Portfolio 15.3.6.3 Financials 15.3.6.4 SWOT Analysis 15.3.7 Fluidigm Corporation 15.3.7.1 Company Overview 15.3.7.2 Product Portfolio 15.3.7.3 Financials 15.3.8 Illumina, Inc 15.3.8.1 Company Overview 15.3.8.2 Product Portfolio 15.3.8.3 Financials 15.3.8.4 SWOT Analysis 15.3.9 Perkinelmer, Inc 15.3.9.1 Company Overview 15.3.9.2 Product Portfolio 15.3.9.3 Financials 15.3.9.4 SWOT Analysis 15.3.10 Thermo Fisher Scientific, Inc 15.3.10.1 Company Overview 15.3.10.2 Product Portfolio 15.3.10.3 Financials 15.3.10.4 SWOT Analysis